This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2001;285:1954-1955.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2001;50:204-206

During the 1990s, the number of tuberculosis (TB) cases increased dramatically in the Russian Federation,^1-3 and the rise paralleled concomitant increases in TB-associated mortality.^2-3 In November 1998, the World Health Organization (WHO), the U.S. Agency for International Development, and CDC, in collaboration with the Central Tuberculosis Research Institute of the Russian Academy of Medical Sciences and the Russian Ministry of Health, identified three regions as demonstration sites for implementing a WHO control strategy program of directly observed treatment short-course (DOTS). The program was designed to provide comprehensive TB care to both civilian and prison populations within each region (oblast), and periodic cohort analyses of treatment outcomes were recommended to evaluate its progress. This report summarizes evaluations of treatment outcomes for patients enrolled during the first 6 months of the project in Orel oblast and indicates that treatment success rates among TB patients in Orel were high. These findings . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?